Dr. Upal Roy
Florida International University, USA
Email: uroy@fiu.edu
Qualifications
2005 Ph.D., Goa University, India
1999 M.S.,
Marathwada University, India
1997 B.S.,
Marathwada University, India
Publications (selected)
-
Upal Roy, C Bulot, K H Z Bentrupand DMondal.2013.
Specific Increase in MDR1 Mediated Drug-Efflux in Human Brain Endothelial Cells
Following Co-exposure to HIV-1 and Saquinavir. PLoS One. 2013 Oct
3;8(10):e75374.
-
SL Gerlach, M Yeshak, U Göransson, Upal Roy,
R Izadpanah, D Mondal. 2013. Cycloviolacin O2 (CyO2) suppresses productive
infection and augments the antiviral efficacy of nelfinavir in HIV-1 infected
monocytic cells.Biopolymers. 2013;100(5):471-479.(PMID:23897405)
-
N Gautam, UpalRoy , S Balkundi, P Puligujja, D
Guo, N Smith, XM Liu, B Lamberty, B Morsey, H Fox, J McMillan, HE Gendelman, Y
Alnouti, 2013. Preclinical Pharmacokinetics and Tissue Distribution of
Long-Acting Nanoformulated Antiretroviral Therapy. Antimicrob. Agents
Chemother. 57(7):3110-20.
-
Upal Roy, J McMillan, Y Alnouti, N Gautum, N
Smith, S Balkundi, P Dash, S Gorantla, A Martinez-Skinner, J Meza, G Kanmogne,
S Swindells, S.M. Cohen, R.L Mosley, L Poluektova , H.E. Gendelman. 2012.
Pharmacodynamic and antiretroviral activities of combination
nanoformulatedantiretrovirals in HIV-1-infected human PBLreconstituted mice.J
infectious Disease.206(10):1577-88. (Citation-7)
-
P. Dash, H.E. Gendelman, Upal Roy, S.
Balkundi, T.Gutti, J.Knibbe, E. Makarov, N. Smith, Y. Alnouti, R. L. Mosley,
H.A. Gelbard, J. McMillan, S. Gorantla, and L.Poluektova. 2012 .Long-acting
Nanoformulated Protease Inhibitors Show Potent Antiretroviral Responses in
HIV-1 Infected Humanized Mice. AIDS.26(17):2135-44.(Citation – 6)
-
G.D. Kanmogne, S. Singh, Upal Roy, X. Liu, J
McMillan,SGorantla, S Balkundi, N Smith, Y Alnouti, N Gautam,Y Zhou, L
Poluektova, A Kabanov, T Bronich and H E.Gendelman.2012.Mononuclear phagocyte
intercellular crosstalk facilitates transmission of cell targeted nanoformulated
antiretroviral drugs to human brain endothelial cells. International
Journal of Nanomedicine 7.1-16.(Citation – 6)
-
S Balkundi, A.S. Nowacek, R.S. Veerubhotla, H
Chen, A Martinez-Skinner, Upal Roy, RL Mosley, G Kanmogne, X Liu, A.V. Kabanov,
T Bronich, J McMillan, H.E. Gendelman.2011. Comparative manufacture and
cell-based delivery of antiretroviral nanoformulations. International
Journal of Nanomedicine.6:3393-404.(Citation – 9)
-
J Huang,N Gautam, SP Bathena, Upal Roy,J
McMillan, HE Gendelman, Y Alnouti.2011. UPLC-MS/MS quantification of
nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum
and tissues.Journal of Chromatography B879(23):2332-8.(Citation – 5)
-
TZ Nazari-Shafti,E Freisinger,UpalRoy,CTBulot, C
Senst, CL Dupin, AE Chaffin, SK Srivastava, D Mondal, EU Alt, R Izadpanah.
2011.Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1
infection.Retrovirology.12;8(1):3. (Article is considered as 'Highly
accessed' relative to age)(Citation – 1)
-
S Balkundi,ASNowacek, UpalRoy, A
Martinez-Skinner, J McMillan, H. E. Gendelman.2010. Methods Development for
Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral
Drugs. Journal of Visual Experiments (46):pii 2460.doi.10.3791/2460.
(Citation – 9)
-
AS Nowacek, S Balkundi, J McMillan ,
Upal Roy , A Martinez-Skinner , RL Mosley , G Kanmogne, AV Kabanov,
T Bronich, HE Gendelman. 2011. Analyses of nanoformulated
antiretroviral drug charge, size, shape and content for uptake, drug release
and antiviral activities in human monocyte-derived macrophages. Journal of
Control Release.150(2):204-11.(Citation – 25)
-
Upal Roy, G Chakravarty, K Honer
Zu Bentrup , D Mondal. 2009. Montelukast is a potent and
durableinhibitor of multidrug resistance protein 2-mediated efflux of taxol and
saquinavir.Biological & pharmaceutical bulletin 32(12):2002-9.(Citation
– 9)
-
Upal Roy, S A. Simpson, D Mondal, S
Eloby-Childress, E L. Winsor, M A. Beilke. 2008. Up-regulation of HTLV-1 and
HTLV-2 expression by HIV-1 in vitro. Journal of Medical Virology.
80(3):494-500.(Citation – 5).
-
M. A. Eilers, Upal Roy and D. Mondal. 2008.MRP
(ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and
zidovudine, from human endothelial cells. Experimental Biology and
Medicine. (Maywood). 233(9).1149-1160. (Citation – 35)
-
R Dixit, Upal Roy, Mi S. Patole, Y S.
Shouche.2008. Molecular and Phylogenetic analysis of a novel family of
fibrinogenrelated proteins from mosquito Aedesalbopictuscell
line. Computational Biology and Chemistry 32. 382-386. (Citation – 5)
-
R. Dixit., S. Dixit., UpalRoy, Y. Shouche and S
Gakhar.2007. Partial genomic organization of ribosomal protein S7 gene from
malaria vector Anopheles stephensi.Insect Science.14.
65-75. (Citation – 2)
-
UpalRoy, D Nair.2007. Biodiversity of organotin
resistant Pseudomonas from west coast ofIndia. Ecotoxicology. 16
(2), 253-261.(Citation – 3)
-
T.P. Anand, A. W. Bhat., Y.S. Shouche., Upal Roy,
J. Siddharth., S. P. Sharma. 2006. Antimicrobial activity of marine bacteria
associated with marine sponges from the waters off the coast of south east
India. Microbiological Research.161. 252-262. (Citation – 59)
-
Upal Roy and S. Bhosle. 2006. Microbial
transformation of tributyltin chloride by Pseudomonas
aeruginosa strain USS25 NCIM-5224. Applied Organometallic
Chemistry.20. 5-11.(Citation – 5)
-
Upal Roy; S.K Dubey and S.
Bhosle. 2004Tributyltin chloride degrading bacteria from marine
environment of west coast of India. Current Science.85.702-705. (Citation
– 12)
-
Upal Roy, S. K. Dubey and S.
Bhosle.2001.“Characterisation of Exopolymer Produced by Sphingomonas sp.
Utilizing TBTC”. Proceedings of International Conference on Industrial
Pollution and Control Technologies (ICIPACT-2001, JNTU, Hyderabad),639-642.
-
S.K. Dubey andUpalRoy. 2003 Biodegradation of
Tributyltins (organotins) by Marine Bacteria. Applied
Organometallic Chemistry.17. 3-8. (Citation – 67)